This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures
LUMENDI RECEIVES CE MARK FOR DILUMEN™ EZ¹ AND DILUMEN™ C¹, EXPANDING FOOTPRINT IN THE EUROPEAN MARKET
This certification is a key milestone in our global strategy to expand access to minimally invasive endoluminal procedures
Lumendi shines at TxIEG 2025, a record-breaking year for the company with unprecedented interest in the DiLumen Endoluminal Interventional Platform.
Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.